| Emerging benefits of angiotensin converting enzyme inhibitors versus other antihypertensive agents. | |
| | |
MedLine Citation:
|
PMID: 3064606 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The benefit of treatment of mild to moderate hypertension is minimal over the short term. Hence, sustained control of high blood pressure over many years is required. Under these circumstances, the adverse effects of conventional antihypertensive therapy with diuretics and beta-blockers assume great importance, especially hypokalemia and alterations in blood lipid levels. These metabolic changes can negate the benefit of lowered blood pressure. The adverse effects of antihypertensive drugs, especially on the quality of life of hypertensive patients, have recently received a great deal of attention. Angiotensin converting enzyme inhibitors are free of these adverse effects and may actually enhance the quality of life. They are effective antihypertensive agents when given in low doses, they can often be given once a day, and they are effective in all age groups. Combined with a diuretic they are effective in black and elderly hypertensive patients. |
| | |
Authors:
|
J A Schoenberger |
Related Documents
:
|
16735816 - Hypertension and anesthesia. 1839356 - The treatment of hypertension: new lamps for old? 17151696 - Erectile dysfunction and hypertension. 9610036 - Hypertension and the eye: applications of the sixth report of the joint national commit... 9548096 - Relationship between anal canal diameter and pressure evaluated simultaneously by endos... 11855246 - Intracranial pressure monitoring and assessing intracranial compliance in brain injury. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: The American journal of medicine Volume: 84 ISSN: 0002-9343 ISO Abbreviation: Am. J. Med. Publication Date: 1988 Apr |
Date Detail:
|
Created Date: 1989-03-02 Completed Date: 1989-03-02 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0267200 Medline TA: Am J Med Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 30-5 Citation Subset: AIM; IM |
Affiliation:
|
Department of Preventive Medicine, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angiotensin-Converting Enzyme Inhibitors
/
adverse effects,
therapeutic use* Antihypertensive Agents / adverse effects, therapeutic use* Captopril / adverse effects, therapeutic use Humans Hypertension / drug therapy* Patient Compliance |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents; 62571-86-2/Captopril |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Safety issues during antihypertensive treatment with angiotensin converting enzyme inhibitors.
Next Document: New trends in the use of angiotensin converting enzyme inhibitors in chronic heart failure.